Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone.

Background: Gabapentin may help manage opioid withdrawal symptoms, but its effectiveness during buprenorphine taper and transition to naltrexone is uncertain.Objectives: To assess gabapentin's efficacy in improving outcomes for lifetime prescription…

Preview only. Read the full abstract at the source